MPLT

MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. (MPLT) has 16 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 25, 2026.

The most active filer is Chief Executive Officer Kroeger Christopher A. with 7 filings. Insiders have net sold $11.5M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Christopher A. Kroeger
  • Employees:109
  • HQ:Redwood City, CA, US
  • IPO:2025-10-24

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$11.5M

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$1.7B

latest known value

Source
Sale$3.2MMay 19SEC ↗
Sale$419KMay 12SEC ↗
Sale$576KMay 12SEC ↗
Sale$953KMay 12SEC ↗
Sale$421KMay 12SEC ↗
Sale$127KMay 12SEC ↗
Sale$20KMay 12SEC ↗
Setia VishwasFirst filing
Sale$419KMay 7SEC ↗
Setia VishwasFirst filing
Sale$307KMay 7SEC ↗
Setia VishwasFirst filing
Sale$298KMay 7SEC ↗
Foff Erin PennockFirst filing
Sale$438KMay 7SEC ↗
Foff Erin PennockFirst filing
Sale$298KMay 7SEC ↗
Foff Erin PennockFirst filing
Sale$692KMay 7SEC ↗
Sale$442KMay 7SEC ↗
Sale$313KMay 7SEC ↗
Sale$714KMay 7SEC ↗
Hanson KristopherFirst filing
Sale$388KMay 7SEC ↗
Sale$435KMay 7SEC ↗
Sale$295KMay 7SEC ↗
Sale$682KMay 7SEC ↗

Related companies

MapLight Therapeutics, Inc. is in the Healthcare sector.